NANOG and breast cancer: Concordant with our findings, LINC00511 was shown to accelerate the G1/S shift and prevent apoptosis in ER-negative breast cancer [26], and manipulation of LINC00511 expression confirmed a role in tumorigenesis and stemness through miR-185-3p/E2F1/Nanog axis in breast cancer [27].